← Open Payments lookup

AMANDA BARFIELD: Open Payments

NPI 1902257009 · LAFAYETTE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$639 in 30 payments from 10 companies in 2025. Trend: 2023 $527 · 2024 $429 · 2025 $639

Food & beverage: $639
CompanyPaymentsAmount
Vanda Pharmaceuticals Inc.6$175
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)9$148
Otsuka America Pharmaceutical, Inc.4$79
Axsome Therapeutics, Inc.2$54
E.R. Squibb & Sons, L.L.C.3$54
Neurocrine BioSciences, Inc.2$51
ABBVIE INC.1$24
Teva Pharmaceuticals USA, Inc.1$22
Novo Nordisk Inc1$17
Exact Sciences Corporation1$15

Products named: FANAPT, CAPLYTA, Auvelity, COBENFY, INGREZZA, REXULTI, ABILIFY ASIMTUFII, VRAYLAR.

Industry payments across LA — which companies pay providers there.